DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Remus Pharmaceuticals Limited — Record Date

NSE 1 hr ago·7 Sept 2026, 3:30 pm

Remus Pharmaceuticals L

Remus Pharmaceuticals has announced that September 22, 2026, will be the record date for its upcoming dividend. This means that shareholders must own the stock by this date to be eligible to receive the declared dividend payment.

This announcement is significant for investors as it sets the timeline for dividend eligibility. The company will process the dividend distribution to those on its register of members on the specified date, marking a key milestone for shareholders.

Investors should watch for the final dividend declaration and the actual payment date, which will be announced later. Keeping track of these dates helps in planning their investment returns effectively.